A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. oleh Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, Angela Bosco-Lauth, Christopher Fox, Richard A Bowen, David E Clements, Timothy Martyak, D Elliot Parks, Susan Baldwin, Steven G Reed, Rhea N Coler